Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14740%2F15%3A00084162" target="_blank" >RIV/00216224:14740/15:00084162 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00209805:_____/15:#0000687 RIV/65269705:_____/15:00063848

Výsledek na webu

<a href="http://www.mdpi.com/1422-0067/16/10/23382" target="_blank" >http://www.mdpi.com/1422-0067/16/10/23382</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3390/ijms161023382" target="_blank" >10.3390/ijms161023382</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma

Popis výsledku v původním jazyce

Serum microRNAs are emerging as a clinically useful tool for early and non-invasive detection of various cancer types including renal cell carcinoma (RCC). Based on our previous results, we performed the study to analyze circulating serum miR-378 and miR-210 in patients with various histological subtypes of RCC. RNA was purified from blood serum samples of 195 RCC patients and 100 healthy controls. The levels of miR-378 and miR-210 in serum were determined absolutely using quantitative real-time PCR. Pre- and postoperative levels of both microRNAs were compared in 20 RCC patients. Significantly increased serum levels of both miR-378 and miR-210 enabled to clearly distinguish RCC patients and healthy controls with 80% sensitivity and 78% specificity ifanalyzed in combination (p &lt; 0.0001), and their levels significantly decreased in the time period of three months after radical nephrectomy (p &lt; 0.0001). Increased level of miR-378 positively correlates with disease-free survival (p

Název v anglickém jazyce

Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma

Popis výsledku anglicky

Serum microRNAs are emerging as a clinically useful tool for early and non-invasive detection of various cancer types including renal cell carcinoma (RCC). Based on our previous results, we performed the study to analyze circulating serum miR-378 and miR-210 in patients with various histological subtypes of RCC. RNA was purified from blood serum samples of 195 RCC patients and 100 healthy controls. The levels of miR-378 and miR-210 in serum were determined absolutely using quantitative real-time PCR. Pre- and postoperative levels of both microRNAs were compared in 20 RCC patients. Significantly increased serum levels of both miR-378 and miR-210 enabled to clearly distinguish RCC patients and healthy controls with 80% sensitivity and 78% specificity ifanalyzed in combination (p &lt; 0.0001), and their levels significantly decreased in the time period of three months after radical nephrectomy (p &lt; 0.0001). Increased level of miR-378 positively correlates with disease-free survival (p

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

International Journal of Molecular Sciences

ISSN

1422-0067

e-ISSN

—

Svazek periodika

16

Číslo periodika v rámci svazku

10

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

8

Strana od-do

23382-23389

Kód UT WoS článku

000364232100016

EID výsledku v databázi Scopus

—